Home > Insider Trading > Filing (0001209191-13-035979)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1502917	Christiana Stamoulis	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139	Svp, Corp Strategy & Bus Devlp	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-07-05	4,687	$34.57	45,399	No	4	M	Direct
Common Stock	Disposition	2013-07-05	1,300	$80.65	44,099	No	4	S	Direct
Common Stock	Disposition	2013-07-05	3,387	$81.42	40,712	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2013-07-05	4,687	$0.00	4,687	$34.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,688	2010-01-05	2019-10-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	939	Indirect	401(k)

Footnotes

Transaction made pursuant to Ms. Stamoulis' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $80.65 (range $80.25 to $80.99).
Ms. Stamoulis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $81.42 (range $81.01 to $81.77).
The option vests in 16 quarterly installments beginning on 10/05/2009.